DexCom Price to Book Ratio 2012-2025 | DXCM
Historical price to book ratio values for DexCom (DXCM) over the last 10 years. The current price to book ratio for DexCom as of February 09, 2026 is 10.38.
| DexCom Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-02-10 | 68.16 | 9.75 | |
| 2025-09-30 | 67.29 | $6.99 | 9.63 |
| 2025-06-30 | 87.29 | $6.56 | 13.30 |
| 2025-03-31 | 68.29 | $5.78 | 11.81 |
| 2024-12-31 | 77.77 | $5.38 | 14.45 |
| 2024-09-30 | 67.04 | $5.07 | 13.23 |
| 2024-06-30 | 113.38 | $6.08 | 18.66 |
| 2024-03-31 | 138.70 | $5.67 | 24.45 |
| 2023-12-31 | 124.09 | $5.37 | 23.12 |
| 2023-09-30 | 93.30 | $5.87 | 15.90 |
| 2023-06-30 | 128.51 | $5.44 | 23.62 |
| 2023-03-31 | 116.18 | $5.76 | 20.17 |
| 2022-12-31 | 113.24 | $5.52 | 20.52 |
| 2022-09-30 | 80.54 | $4.72 | 17.05 |
| 2022-06-30 | 74.53 | $5.75 | 12.97 |
| 2022-03-31 | 127.90 | $5.58 | 22.92 |
| 2021-12-31 | 134.24 | $5.26 | 25.51 |
| 2021-09-30 | 136.72 | $5.51 | 24.81 |
| 2021-06-30 | 106.75 | $5.16 | 20.67 |
| 2021-03-31 | 89.85 | $4.92 | 18.26 |
| 2020-12-31 | 92.43 | $4.75 | 19.45 |
| 2020-09-30 | 103.06 | $3.90 | 26.40 |
| 2020-06-30 | 101.35 | $3.55 | 28.57 |
| 2020-03-31 | 67.32 | $2.53 | 26.60 |
| 2019-12-31 | 54.69 | $2.41 | 22.70 |
| 2019-09-30 | 37.31 | $2.09 | 17.87 |
| 2019-06-30 | 37.46 | $1.89 | 19.85 |
| 2019-03-31 | 29.78 | $1.84 | 16.21 |
| 2018-12-31 | 29.95 | $1.84 | 16.26 |
| 2018-09-30 | 35.76 | $1.58 | 22.59 |
| 2018-06-30 | 23.75 | $1.36 | 17.42 |
| 2018-03-31 | 18.54 | $1.20 | 15.49 |
| 2017-12-31 | 14.35 | $1.21 | 11.90 |
| 2017-09-30 | 12.23 | $1.10 | 11.07 |
| 2017-06-30 | 18.29 | $1.02 | 17.89 |
| 2017-03-31 | 21.18 | $0.80 | 26.32 |
| 2016-12-31 | 14.93 | $0.84 | 17.80 |
| 2016-09-30 | 21.92 | $0.77 | 28.29 |
| 2016-06-30 | 19.83 | $0.74 | 26.98 |
| 2016-03-31 | 16.98 | $0.69 | 24.50 |
| 2015-12-31 | 20.48 | $0.68 | 30.25 |
| 2015-09-30 | 21.47 | $0.59 | 36.11 |
| 2015-06-30 | 20.00 | $0.53 | 37.49 |
| 2015-03-31 | 15.59 | $0.48 | 32.56 |
| 2014-12-31 | 13.76 | $0.45 | 30.35 |
| 2014-09-30 | 10.00 | $0.38 | 26.57 |
| 2014-06-30 | 9.92 | $0.33 | 30.03 |
| 2014-03-31 | 10.34 | $0.30 | 34.38 |
| 2013-12-31 | 8.85 | $0.29 | 30.53 |
| 2013-09-30 | 7.06 | $0.26 | 27.08 |
| 2013-06-30 | 5.61 | $0.25 | 22.11 |
| 2013-03-31 | 4.18 | $0.26 | 16.06 |
| 2012-12-31 | 3.40 | $0.28 | 12.27 |
| 2012-09-30 | 3.76 | $0.29 | 12.97 |
| 2012-06-30 | 3.24 | $0.33 | 9.78 |
| 2012-03-31 | 2.61 | $0.36 | 7.18 |
| 2011-12-31 | 2.33 | $0.39 | 6.01 |
| 2011-09-30 | 3.00 | $0.42 | 7.16 |
| 2011-06-30 | 3.62 | $0.45 | 8.03 |
| 2011-03-31 | 3.88 | $0.21 | 18.14 |
| 2010-12-31 | 3.41 | $0.25 | 13.89 |
| 2010-09-30 | 3.31 | $0.15 | 22.02 |
| 2010-06-30 | 2.89 | $0.18 | 16.33 |
| 2010-03-31 | 2.44 | $0.20 | 11.97 |
| 2009-12-31 | 2.02 | $-0.10 | -20.15 |
| 2009-09-30 | 1.98 | $-0.05 | -40.13 |
| 2009-06-30 | 1.55 | $0.01 | 143.29 |
| 2009-03-31 | 1.04 | $0.08 | 12.62 |
| 2008-12-31 | 0.69 | $-0.16 | -4.23 |
| 2008-09-30 | 1.55 | $-0.24 | -6.53 |
| 2008-06-30 | 1.51 | $-0.13 | -11.82 |
| 2008-03-31 | 1.04 | $-0.02 | -42.59 |
| 2007-12-31 | 2.21 | $0.06 | 35.55 |
| 2007-09-30 | 2.50 | $0.15 | 16.33 |
| 2007-06-30 | 2.05 | $0.24 | 8.71 |
| 2007-03-31 | 1.97 | $0.32 | 6.12 |
| 2006-12-31 | 2.47 | $0.50 | 4.89 |
| 2006-09-30 | 2.78 | $0.59 | 4.71 |
| 2006-06-30 | 3.40 | $0.70 | 4.88 |
| 2006-03-31 | 5.07 | $0.39 | 12.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $28.288B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.576B | 25.44 |
| Intuitive Surgical (ISRG) | United States | $178.066B | 68.04 |
| IDEXX Laboratories (IDXX) | United States | $51.073B | 48.94 |
| Edwards Lifesciences (EW) | United States | $47.962B | 32.16 |
| IQVIA Holdings (IQV) | United States | $39.378B | 21.96 |
| Alcon (ALC) | Switzerland | $39.263B | 26.46 |
| Mettler-Toledo (MTD) | United States | $28.306B | 33.12 |
| STERIS (STE) | Ireland | $25.934B | 26.77 |
| Waters (WAT) | United States | $22.587B | 29.87 |
| Coloplast (CLPBY) | Denmark | $18.987B | 32.40 |
| Hologic (HOLX) | United States | $16.685B | 17.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.055B | 0.00 |
| Penumbra (PEN) | United States | $13.981B | 98.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.101B | 10.86 |
| Globus Medical (GMED) | United States | $12.005B | 25.20 |
| SARTORIUS (SSSGY) | Germany | $7.821B | 45.42 |
| Masimo (MASI) | United States | $7.435B | 23.82 |
| Glaukos (GKOS) | United States | $6.747B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.917B | 18.80 |
| TransMedics (TMDX) | United States | $4.579B | 54.25 |
| Teleflex (TFX) | United States | $4.568B | 7.28 |
| LivaNova (LIVN) | United Kingdom | $3.645B | 19.69 |
| Veracyte (VCYT) | United States | $3.017B | 34.38 |
| Integer Holdings (ITGR) | United States | $2.998B | 14.07 |
| Elekta AB (EKTAY) | Sweden | $2.282B | 21.34 |
| Alphatec Holdings (ATEC) | United States | $2.152B | 0.00 |
| UFP Technologies (UFPT) | United States | $1.973B | 26.06 |
| Artivion (AORT) | United States | $1.953B | 89.63 |
| Nihon Kohden (NHNKY) | Japan | $1.915B | 16.72 |
| PROCEPT BioRobotics (PRCT) | United States | $1.628B | 0.00 |
| AxoGen (AXGN) | United States | $1.615B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.362B | 0.00 |
| IRadimed (IRMD) | United States | $1.259B | 60.00 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.929B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.869B | 4.71 |
| SiBone (SIBN) | United States | $0.710B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.642B | 37.31 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.625B | 12.47 |
| Pacific Biosciences Of California (PACB) | United States | $0.622B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.603B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.590B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.533B | 0.00 |
| NeuroPace (NPCE) | United States | $0.530B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.445B | 12.27 |
| OrthoPediatrics (KIDS) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.429B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.376B | 0.00 |
| RxSight (RXST) | United States | $0.363B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.352B | 58.71 |
| Sight Sciences (SGHT) | United States | $0.340B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.276B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| CVRx (CVRX) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.186B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.178B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.176B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.168B | 0.00 |
| Inogen (INGN) | United States | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.144B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.128B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.120B | 0.00 |
| Hyperfine (HYPR) | United States | $0.113B | 0.00 |
| Solana (HSDT) | United States | $0.103B | 0.00 |
| Accuray (ARAY) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| DarioHealth (DRIO) | United States | $0.074B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.027B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |